VICTRELIS TRIPLE
VICTRELIS TRIPLE
Discontinued
DIN Number
02371448
Drug Class
Human
Market Date
Aug 16, 2011
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02371448
AIG Number0352956001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AB60 PEGINTERFERON ALFA-2B, COMBINATIONS
Product Specifications
Dosage FormCapsule
,
Powder For Solution
Route of AdministrationSubcutaneous
,
Oral
AHFS Classification08:18.32
Health Canada Classification
ACTIVE INGREDIENTS (3)
BOCEPREVIRActive
Strength: 200 MG / CAP
Monograph: BOCEPREVIR
PEGINTERFERON ALFA-2BActive
Strength: 80 MCG / 0.5 ML
Monograph: PEGINTERFERON ALFA-2B
RIBAVIRINActive
Strength: 200 MG / CAP
Monograph: RIBAVIRIN